Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Abiraterone Acetate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102030798A details a novel triflic acid salting method for Abiraterone Acetate, offering superior filtration and purity over traditional mesylate routes for API manufacturers.
Advanced purification of Abiraterone acetate via oxalate salt formation. Eliminates column chromatography, ensures >99.5% purity, and offers scalable manufacturing solutions.
Patent CN102030798B reveals a novel triflate salt purification method for Abiraterone Acetate. Achieves >97% purity, eliminates chromatography, and ensures scalable supply.
Novel preparation method for Abiraterone acetate reduction impurity ensures high purity. Optimized catalytic hydrogenation and coupling reduce costs for pharmaceutical supply chains.
Patent CN103864878A reveals a novel cross-coupling method for Abiraterone Acetate using organozinc reagents, offering significant cost reduction and improved purity for pharmaceutical intermediates manufacturing.
Patent CN116589519A reveals improved sulfonation and Suzuki coupling for high-purity API intermediate manufacturing with reduced corrosion risks and enhanced scalability.